A Phase 1 interventional study of Weight reduction in Spontaneous Osteonecrosis of the Knee, sponsored by Assaf-Harofeh Medical Center. Status unknown at 1 site in Israel. Open to participants aged 40 Months to 85 Years. Per ClinicalTrials.gov, last updated 2013-09-26.
Sponsored by Assaf-Harofeh Medical Center · Phase 1, Interventional, and Treatment
safety and efficacy of Hyper Baric Oxygen (HBO) in patients presenting with spontaneous osteonecrosis of the knee
182 studies on the registry are indexed under Osteonecrosis; 31 are open to participants now.
This study's planned enrollment of 40 is below the median of 51 across 96 interventional studies indexed under Osteonecrosis.
Browse Osteonecrosis studies →Assaf-Harofeh Medical Center is the lead sponsor of 258 studies on the registry; 40 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
6 weeks of HBO treatment as well as non weight bearing
Biological: Weight reduction
non weight bearing
Biological: Weight reduction
Efficacy
Pain Reduction
Time frame: 6 weeks
Safety
Number of Participants with Adverse Events during HBOT
Time frame: end of HBOT
Reduction In AVN size by MRI
Time frame: 6 weeks
This study is status unknown, as verified in Sep 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Assaf-Harofeh Medical Center